A Phase 2 Multicenter Study of Axicabtagene Ciloleucel in Subjects With Relapsed/Refractory Indolent Non-Hodgkin Lymphoma

Columbia University Medical Center, New York

University of Rochester Medical Center (URMC), Rochester

UPMC Hillman Cancer Center, Pittsburgh

Fox Chase Cancer Center, Philadelphia

Georgetown Lombardi Comprehensive Cancer Center, Washington D.C.

University of Miami Hospital and Clinics, Miami

H Lee Moffitt Cancer Center, Tampa

Sarah Cannon Research Institute, Nashville

Vanderbilt University Medical Center, Nashville

Ohio State University Medical Center, Cleveland

Centre Hospitalier Régional Universitaire de Lille, Lille

Centre Hospitalier Lyon Sud, Pierre-Bénite

MD Anderson Cancer Center, Houston

Banner MD Anderson Cancer Center, Gilbert

USC Norris Comprehensive Cancer Center, Los Angeles

University of California Los Angeles, Los Angeles

Fred Hutchinson Cancer Research Center, Seattle

Dana Farber Cancer Institute, Boston

Hackensack University Medical Center - John Theurer Cancer Center, Hackensack